Dr. Ryan J. Hoefen, MD

Dr. Hoefen practices at Rochester General Hospital in Rochester, New York, part of Rochester Regional Health.

Dr. Hoefen's NPI, 1740392539, was assigned on August 31, 2006. Dr. Hoefen graduated from University of Rochester Medical Center in 2005. Dr. Hoefen holds New York license 243674.

Dr. Hoefen's primary practice is Rochester General Hospital, at 1425 Portland Avenue, Rochester, NY 14621 in Monroe County. The practice phone is (585) 922-4000.

Dr. Hoefen's primary practice is Rochester General Hospital in Rochester, New York, part of Rochester Regional Health. Dr. Hoefen is also affiliated with Strong Memorial Hospital. The medical group on file is Rochester General Hospital. Dmand AI also links Dr. Hoefen to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hoefen practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Hoefen's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Hoefen is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Hoefen is licensed in New York.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic hypertension, coronary artery disease, heart blockage and heart failure among the conditions Dr. Hoefen treats.

CMS data shows 1,551 Medicare services from Dr. Hoefen across 15 procedure codes in 2024, for 868 Medicare patients. Medicare paid $45,543 for them.

CMS counts 868 Medicare patients who saw Dr. Hoefen in 2024. The largest group is 75 to 84, with 277 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hoefen's median patient age at 71, with 54% women.

In 2024, Dr. Hoefen wrote 5,917 Medicare Part D claims for 863 patients. 87% of them were for generic drugs. CMS names the drug for 5,719 of them, across 52 drugs with 11 or more claims each, at $943,323 in total drug cost. In 2023, CMS named 5,127 claims across 52 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Hoefen for performance year 2024, reported through an alternative payment model (APM). Dr. Hoefen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 24 papers to Dr. Hoefen, published from 2009 to 2023. 2020 was the busiest year, with 7. The most frequent topics are Inpatients, Tachycardia, Ventricular and Cell Cycle Proteins. Dr. Hoefen has published most often in Clin Cardiol. Dr. Hoefen's most frequent co-authors are Richard L. Alweis, MD, Abdullah Sayied Abdullah, MD and George Eromosele Eigbire, MD.

CMS Open Payments shows 19 general payments to Dr. Hoefen from 8 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $81.

Dmand AI lists 2 awards for Dr. Hoefen, most recently CMS Stage 1 EHR in 2013.

Dr. Hoefen graduated from University of Rochester Medical Center in 2005. Dr. Hoefen is a member of ACC.

Dr. Hoefen is in network with 18 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.